Browsing Category
Healthcare Industry News
2467 posts
Why Philip Morris is betting big on the U.S. to drive its smoke-free future (NYSE: PM)
Explore how Philip Morris International’s $20B U.S. investment plan could reshape its smoke-free growth strategy, regulatory playbook, and industry leadership.
How Broadwood Partners is reshaping STAAR Surgical’s future after the failed Alcon acquisition proposal
STAAR Surgical signs cooperation pact with Broadwood Partners after rejecting Alcon merger. Find out how this reshapes strategy and investor control.
Can Bluebird Botanicals help cbdMD reclaim leadership in the evolving wellness market?
cbdMD acquires Bluebird Botanicals to expand IP, unify brands, and boost 2026 profitability. Find out how this move reshapes the cannabinoid wellness market.
4DMedical raises (ASX:4DX) $150m to fuel U.S. lung imaging push and expand AI respiratory portfolio
4DMedical raises $150M to scale CT:VQ in the U.S. with minimal dilution. Find out how this move sets the stage for profitability and market leadership.
Singular Health (ASX: SHG) secures fast-track FDA clearance for 3DICOM MD Cloud, strengthening its U.S. commercial leverage
FDA clearance for Singular Health Limited’s 3DICOM MD Cloud opens the U.S. market. Find out what this means for imaging economics and competition.
Little Green Pharma (ASX: LGP) to acquire Cannatrek in all-share deal creating vertically integrated cannabis leader
Discover how Little Green Pharma’s merger with Cannatrek is set to reshape Australia’s cannabis sector and accelerate GMP-certified expansion into Europe.
Firstsource (NSE: FSL) acquires TeleMedik to scale clinical AI services across U.S. health plans
Firstsource acquires TeleMedik to expand AI-powered clinical services for U.S. payers. Find out how this move reshapes healthcare outsourcing strategy.
Veracity enters clean protein market with MyoVera-powered supplement as part of metabolic health expansion strategy
Veracity’s new Metabolic Power Protein uses MyoVera to target metabolism, muscle growth, and safety. Find out how this changes the protein game today.
Smith+Nephew (LSE: SN) to strengthen shoulder surgery strategy with Integrity Orthopaedics acquisition
Smith+Nephew is betting up to $450 million on Tendon Seam to reshape rotator cuff repair. Find out what this deal signals for shoulder surgery.
From healthtech to AI: What Kartika Saran’s CFO move reveals about SPARC’s ambitions
SPARC AI names Kartika Saran as CFO in a move signaling strategic capital readiness. Read why this hire may reshape its investor strategy and scaling plan.